ArticleInternational ophthalmology2025
How patients deal with side-effects of topical intraocular pressure-lowering medication in glaucoma: a cross-sectional study from a tertiary ophthalmology clinic.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Data Volume and the Need for Clinical Decision Support in Glaucoma Care.Ophthalmology science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to evaluate the knowledge, attitudes, and experiences of glaucoma patients about the side effects of intraocular pressure (IOP)-lowering medications in glaucoma, focusing on how these factors affect treatment adherence.
methodsWe conducted a cross-sectional survey during routine visits to glaucoma clinic, with participants aged 18 years or older on IOP-lowering medications for at least 6 months. The survey, consisting of 22 questions about various aspects of IOP-lowering medications and side effects.
resultsMost out of 398 analysed patients were not informed about side effects when IOP-lowering medication was prescribed, and 68.1% reported experiencing side effects. A significant number of participants reported changing IOP-lowering medications due to side effects. Higher self-reported knowledge about side effects was associated with lower concern (coef. = - 0.1636, P = 0.048) about side effects.
conclusionThe study identified significant gaps in patient education and support about IOP-lowering medications side effects. Better communication and education by healthcare providers could improve treatment adherence, consequentially enhancing clinical outcomes and quality of life for glaucoma patients.
Indexed as
Identifiers
40682733What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.